MARKET

INMB

INMB

Inmune Bio Inc
NASDAQ
1.960
-0.040
-2.00%
Opening 12:59 09/29 EDT
OPEN
2.010
PREV CLOSE
2.000
HIGH
2.020
LOW
1.940
VOLUME
219.16K
TURNOVER
--
52 WEEK HIGH
2.600
52 WEEK LOW
1.090
MARKET CAP
54.40M
P/E (TTM)
-2.8311
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at INMB last week (0921-0925)?
Weekly Report · 1d ago
Weekly Report: what happened at INMB last week (0914-0918)?
Weekly Report · 09/21 09:46
INmune Bio Adds Rare Disease, Biopharma Executives Duane Clark And James Sapirstein To Board
NASDAQ · 09/15 08:11
Inmune Bio Adds Strategic Directors to Support Commercialization
TipRanks · 09/14 20:33
*INmune Bio Appointed R. Duane Clark II, James Sapirstein to Bd >INMB
Dow Jones · 09/14 11:01
Weekly Report: what happened at INMB last week (0907-0911)?
Weekly Report · 09/14 09:49
Weekly Report: what happened at INMB last week (0831-0904)?
Weekly Report · 09/07 09:45
Rare Stock Picks In August 2026 - From 21 Discerning Analysts
Seeking Alpha · 09/04 12:00
More
About INMB
INmune Bio Inc. is a clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. The Company has three product platforms. The Dominant-Negative Tumor Necrosis Factor (DN-TNF) product platform utilizes dominant-negative technology to selectively neutralize soluble TNF. DN-TNF product candidates are in clinical trials to determine if they can treat Mild Alzheimer’s disease, Mild Cognitive Impairment and treatment-resistant depression (XPro). The Natural Killer Cell Priming Platform includes INKmune, developed to prime a patient’s NK cells to eliminate minimal residual disease in patients with cancer and is in trials in metastatic castration-resistance prostate cancer. The third program, CORDStrom, is a proprietary pooled, allogeneic, human umbilical cord-derived mesenchymal Stromal/Stem cell (hucMSCs) platform that has completed a trial in recessive dystrophic epidermolysis bullosa.

Webull offers INmune Bio Inc stock information, including NASDAQ: INMB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INMB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INMB stock methods without spending real money on the virtual paper trading platform.